myTomorrows, a global health technology company connecting patients with all possible treatment options, has announced its expansion into the Asia-Pacific (APAC) region and the opening of a new operations hub in India. In recent years, India has seen significant investments in healthcare and the clinical development ecosystem, making it a natural step into the APAC region for an organisation that transforms equitable access to pre-approval treatments. The expansion will allow the company to harness its extensive experience in combining human-led solutions with the latest technologies to support BioPharma companies across patient recruitment, expanded access and Real-World Data (RWD), helping them better service patients and physicians across the entire APAC market.
Through its self-service AI-powered platform, to date, myTomorrows has helped more than 11,000 patients and 2,000 physicians in over 40 countries discover and access pre-approval treatment options. Its platform utilises AI to conduct comprehensive searches of public clinical trial registries, enabling healthcare professionals to quickly and seamlessly identify and refer patients to relevant clinical trials or, where applicable, expanded access programmes (EAPs). Meanwhile, patients and their families are supported throughout the treatment discovery and access journey by the myTomorrows network of Patient Navigators trained with a medical background.
“Our expansion into the APAC region is a significant milestone in furthering our mission of ensuring all patients are fully aware of the treatment options available to them, no matter where they are located in the world,” said Michel van Harten, MD, CEO of myTomorrows. “Our technology is primed to play a leading role in supporting the region’s clinical trial ecosystem, which is currently undergoing a period of considerable growth. I am excited to see our APAC team grow and thrive and look forward to witnessing our potentially life-changing impact for patients and their families.”
